![]() LTS Lohmann Therapie-Systeme LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances. | ![]() India Globalization Capital India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. | ![]() KSQ Therapeutics KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies. | |||
Founding Date | Founding Date 2018 | Founding Date 1984 | Founding Date 2004 | Founding Date 2005 | Founding Date 2015 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations HK HQ | Locations Andernach, DE HQ Shanghai, CN West Caldwell, US | Locations Ramachandrapuram, IN HQ Sangareddy, IN Veliminedu, IN Yavapur, IN | Locations Bethesda, US HQ | Locations Cambridge, US HQ |
Employees | Employees 498 | Employees 2991% increase | Employees 1832% increase | Employees 50150% increase | Employees 871% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥934.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $869k (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥89.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $572k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥852.5m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $297k (FY, 2025) | Gross profit N/A |
Net income | Net income ¥258.9m (FY, 2025) | Net income N/A | Net income N/A | Net income ($4.1m) (FY, 2025) | Net income N/A |

LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.
View companyArene Lifesciences is a manufacturer of pharmaceutical ingredients.
View company
India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.
View company
KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies.
View company